New

Chrome Plugin Live! Redefine the way you read FinTwit 🚀 Install Now

You have successfully sign out
Loading...
Shape
Centessa Pharmaceuticals plc
CNTA
Shape
US Flag

NASDAQ

Unprofitable

EPS improving

Unprofitable

EPS improving

2B

Biotechnology

Next Earning date - 27 Mar 2025

2B

Biotechnology

Next Earning date - 27 Mar 2025

17.07USD

Shape-0.55 ( -3.12%)
Market Closed (as of Feb 14, 21:00 EDT)
favorite-chart

Relative Strenght

84
favorite-chart

Volume Buzz

198%
favorite-chart

Earning Acce

No
favorite-chart

Dist 52w H.

11%

Quote Panel

Shape
Updated February 17, 2025
1W -1.10 % 1M 3.71 % 3M 6.02 % 1Y 60.13 %

Key Metrics

Shape
  • Market Cap

    2.25B


  • Shares Outstanding

    131.66M


  • Share in Float

    90.14M


  • Dividende

    0


  • Earning Date

    27 Mar 2025


  • Price Target

    17.07


  • Average Volume

    704886


  • Beta

    1.535


  • Range

    7.75-19.09


  • Industry

    Biotechnology


  • Website

    https://www.centessa.com


  • Sector

    Healthcare


Fundamentals

Shape

Relative Strength

Shape

CNTA

Sector

loading...

Top 5 RS in Group

Symbol

Company

RS

5-Day Perf.

Forecast

Shape

$270K

ShapeNaN%

2025-Revenue

$1.55

Shape-318%

2025-EPS

$162K

Shape100%

2025-EBITDA

Analyst rating

Strong Sell

Sell

Buy

Neutral

Strong Buy

Shape

Buy

Price Target

0.00(-100.00%)

Number of analyst

0

Last analyst upgrade/downgrade

Morgan Stanley

upgrade

Previous: Equal-Weight

2024-09-19

Now: Overweight

B. Riley

initialise

Previous: Not converted

2024-09-18

Now: Buy

Oppenheimer

initialise

Previous: Not converted

2024-07-18

Now: Outperform

Morgan Stanley

downgrade

Previous: Overweight

2022-08-12

Now: Underweight

Earnings GrowthShape

status-upYoY

Current

Estimates

Q4.22

arrow
arrow

N/A

-0.45
vs -0.68

Q1.23

arrow
arrow

N/A

-0.53
vs -0.60

Q2.23

arrow
arrow

N/A

-0.26
vs -0.69

Q3.23

arrow
arrow

N/A

-0.40
vs -0.57

Q4.23

arrow
arrow

N/A

-0.38
vs -0.45

Q1.24

arrow
arrow

N/A

-0.38
vs -0.53

Q2.24

arrow
arrow

N/A

-0.40
vs -0.26

Q3.24

arrow
arrow

N/A

-0.37
vs -0.40

Q4.24

arrow
arrow

N/A

-0.42
vs -0.38

Q1.25

arrow
arrow

N/A

-0.39
vs -0.38

Sales GrowthShape

status-upYoY

Current

Estimates

Q2.22

arrow
arrow

NA

NA  vs NA

Q3.22

arrow
arrow

NA

NA  vs NA

Q4.22

arrow
arrow

NA

NA  vs NA

Q1.23

arrow
arrow

NA

NA  vs NA

Q2.23

arrow
arrow

NA

NA  vs NA

Q3.23

arrow
arrow

NA

NA  vs NA

Q4.23

arrow
arrow

NA

6.9M  vs NA

Q1.24

arrow
arrow

NA

NA  vs NA

Q2.24

arrow
arrow

NA

NA  vs NA

Q3.24

arrow
arrow

NA

NA  vs NA

Return on EquityShape

status-upQoQ

Q4.22

arrow
arrow

-13%

-0.13
vs -0.14

Q1.23

arrow
arrow

-17%

-0.17
vs -0.13

Q2.23

arrow
arrow

-9%

-0.09
vs -0.17

Q3.23

arrow
arrow

-15%

-0.15
vs -0.09

Q4.23

arrow
arrow

-16%

-0.16
vs -0.15

Q1.24

arrow
arrow

-18%

-0.18
vs -0.16

Q2.24

arrow
arrow

-15%

-0.15
vs -0.18

Q3.24

arrow
arrow

-9%

-0.09
vs -0.15

Institutionnal OwnershipShape

status-upQoQ

Q1.23

arrow
arrow

43

43
vs 43

NA

Q2.23

arrow
arrow

46

46
vs 43

7%

Q3.23

arrow
arrow

50

50
vs 46

9%

Q4.23

arrow
arrow

61

61
vs 50

22%

Q1.24

arrow
arrow

71

71
vs 61

16%

Q2.24

arrow
arrow

82

82
vs 71

15%

Q3.24

arrow
arrow

106

106
vs 82

29%

Q4.24

arrow
arrow

118

118
vs 106

11%

Earnings Growth

Latest News